Concepedia

Author

Hirokazu Honda

Showa UniversityORCID

Also Known As

H Honda, H. Honda, Hideki Hirakata, Hirokazu HONDA, Hirokazu Honda, Honda, H., Takashi Wada

136

Publications

3.5K

Citations

22

H-Index

57

Concepts

All Affiliations

Showa UniversityKawasaki HospitalShowa University Koto Toyosu HospitalEbara (Japan)Karolinska University Hospital
HH

About

Hirokazu Honda is an author at Showa University specializing in medicine, chronic kidney disease, and nephrology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

14

1.3K

2

Health Sciences

5

5

291

3

Public Health

3

3

618

4

Applied Physiology

1

1

14

5

Clinical Nutrition

1

1

14

Hirokazu Honda

×

33

Publications

2.1K

Citations

20

H-Index

YearCitations

Serum Albumin, C-Reactive Protein, Interleukin 6, and Fetuin A as Predictors of Malnutrition, Cardiovascular Disease, and Mortality in Patients With ESRD

Hirokazu Honda, Abdul Rashid Qureshi, Olof Heimbürger,

American Journal of Kidney Diseases

2005

518

Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality

Hirokazu Honda, Abdul Rashid Qureshi, Jonas Axelsson,

American Journal of Clinical Nutrition

2007

281

2015 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease

Hiroyasu Yamamoto, Shinichi Nishi, Tadashi Tomo,

Renal Replacement Therapy

2017

232

Truncal fat mass as a contributor to inflammation in end-stage renal disease

Jonas Axelsson, Abdul Rashid Qureshi, Mohammed E. Suliman,

American Journal of Clinical Nutrition

2004

197

Glomerular and Serum IgG Subclasses in Diffuse Proliferative Lupus Nephritis, Membranous Lupus Nephritis, and Idiopathic Membranous Nephropathy.

Aki Kuroki, Takanori Shibata, Hirokazu Honda,

Internal Medicine

2002

123

Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients

Hirokazu Honda, Masashi Ueda, Shiho Kojima,

Atherosclerosis

2011

88

Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis

Hirokazu Honda, Yasuna Kobayashi, Shoko Onuma,

PLoS ONE

2016

64

Efficacy and safety of interleukin-6 inhibition with ziltivekimab in patients at high risk of atherosclerotic events in Japan (RESCUE-2): A randomized, double-blind, placebo-controlled, phase 2 trial

Yukihiro Wada, Camilla Jensen, Anna Sina P. Meyer,

Journal of Cardiology

2023

44

High-Density Lipoprotein Subfractions and Their Oxidized Subfraction Particles in Patients with Chronic Kidney Disease

Hirokazu Honda, Tsutomu Hirano, Masashi Ueda,

Journal of Atherosclerosis and Thrombosis

2015

41

A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy

Motonori Sugiyama, Yukihiro Wada, Nobuhiro Kanazawa,

PLoS ONE

2020

35

Page 1